Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | OPRL1 | P41146 | 10/20 | 0.57 |
| ▸ | OPRM1 | P35372 | 10/20 | 0.57 |
| ▸ | OPRK1 | P41145 | 8/20 | 0.57 |
| ▸ | OPRD1 | P41143 | 6/20 | 0.57 |
| ▸ | HTT | P42858 | 3/20 | 0.42 |
| ▸ | KCNH2 | Q12809 | 2/20 | 0.40 |
| ▸ | HTR3E | A5X5Y0 | 1/20 | 0.40 |
| ▸ | HTR3B | O95264 | 1/20 | 0.40 |
| ▸ | HTR3A | P46098 | 1/20 | 0.40 |
| ▸ | HTR3D | Q70Z44 | 1/20 | 0.40 |
| ▸ | HTR3C | Q8WXA8 | 1/20 | 0.40 |
| ▸ | GRIN2D | O15399 | 1/20 | 0.39 |
| ▸ | GRIN3B | O60391 | 1/20 | 0.39 |
| ▸ | CYP2B6 | P20813 | 1/20 | 0.39 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.39 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.39 |
| ▸ | PRCP | P42785 | 1/20 | 0.39 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.39 |
| ▸ | GRIN1 | Q05586 | 1/20 | 0.39 |
| ▸ | GRIN2A | Q12879 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7093781 | 0.93 | OPRL1 (0.57) | OPRL1OPRM1OPRK1OPRD1KCNH2 | |
| SCHEMBL7090555 | 0.89 | OPRL1 (0.66) | OPRL1OPRM1OPRK1OPRD1HTT | |
| SCHEMBL7094032 | 0.89 | OPRM1 (0.71) | OPRL1OPRM1OPRK1OPRD1KCNH2 | |
| SCHEMBL7095645 | 0.89 | OPRM1 (0.71) | OPRL1OPRM1OPRK1OPRD1KCNH2 | |
| SCHEMBL7095902 | 0.89 | OPRM1 (0.71) | OPRL1OPRM1OPRK1OPRD1KCNH2 | |
| SCHEMBL7095144 | 0.83 | OPRL1 (0.53) | OPRL1OPRM1OPRK1OPRD1KCNH2 | |
| SCHEMBL7091407 | 0.80 | OPRM1 (0.58) | OPRL1OPRM1OPRK1OPRD1KCNH2 | |
| SCHEMBL7093813 | 0.80 | OPRM1 (0.58) | OPRL1OPRM1OPRK1OPRD1KCNH2 | |
| SCHEMBL7092510 | 0.80 | OPRM1 (0.58) | OPRL1OPRM1OPRK1OPRD1KCNH2 | |
| SCHEMBL6476773 | 0.79 | OPRM1 (0.58) | OPRL1OPRM1OPRK1OPRD1KCNH2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20030109549-A1 | 2-Substituted-1-piperidyl benzimidazole compounds as ORL1-receptor agonists | ITO FUMITAKA (JP) | 2003-06-12 | — | — | US | disclosed |
| EP-1102762-B1 | 2-SUBSTITUTED-1-PIPERIDYL BENZIMIDAZOLE COMPOUNDS AS ORL1-RECEPTOR AGONISTS | PFIZER (US) | 2002-11-13 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030109549-A1 | 2-Substituted-1-piperidyl benzimidazole compounds as ORL1-receptor agonists | OPRL1, ORMDL3, OPRM1 | OPRL1 1/4885OPRM1 3/4885OPRK1 6/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.